Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barclays Analyst Reiterates EqualWeight Rating on Ormat Technologies with Revised Price Target

Elaine Mendonca by Elaine Mendonca
February 5, 2024
in Breaking News
0
Renewable energy
0
SHARES
6
VIEWS
Share on FacebookShare on Twitter

On February 5, 2024, Barclays analyst Derek Podhaizer reiterated his “Equal-Weight” rating on Ormat Technologies (NYSE:ORA) while revising the price target downward from $82 to $75. This suggests that Barclays expects the stock to align with the overall market performance. The decision to lower the price target could have been influenced by a range of factors such as the company’s performance, prevailing market conditions, or emerging industry trends. Investors should take this adjustment into account when making their investment decisions.

ORA Stock Exhibits Downward Trend: Analysis and Potential Rebound

On February 5, 2024, ORA stock exhibited a downward trend. ORA was trading near the bottom of its 52-week range and below its 200-day moving average. The stock experienced a decrease of $0.84 since the market last closed, representing a drop of 1.27%. The stock closed at $65.55. In pre-market trading, ORA’s stock dropped an additional $0.52. Trading near the bottom of its 52-week range suggests that ORA’s stock price is currently at a relatively low level compared to its performance over the past year. Trading below its 200-day simple moving average indicates that ORA’s stock price is below its average price over the past 200 days. Investors and analysts will likely closely monitor ORA’s stock performance in the coming days to assess whether the downward trend continues or if there are any signs of a potential rebound. It is important for investors to conduct thorough research and analysis before making any investment decisions.

ORA Stock Shows Promising Performances with Significant Revenue and Income Growth in 2024

On February 5, 2024, ORA stock showed promising performances based on the data provided by CNN Money. The company’s total revenue for the past year was reported at $734.16 million, with a significant increase of 10.72% compared to the previous year. The total revenue for the third quarter of the same year amounted to $208.06 million, showing a growth of 6.81% since the previous quarter.

ORA’s net income for the past year was recorded at $65.84 million, marking a 6.04% increase compared to the previous year. The net income for the third quarter of 2024 was reported at $35.45 million, indicating a substantial growth of 46.55% since the previous quarter.

ORA’s earnings per share (EPS) for the past year were reported at $1.17, with a 5.85% increase compared to the previous year. The EPS for the third quarter of 2024 was recorded at $0.59, showing an impressive growth of 46.69% since the previous quarter.

Overall, ORA’s stock performances on February 5, 2024, were highly positive. The company demonstrated a remarkable increase in total revenue, net income, and earnings per share. These results indicate that ORA has been successful in growing its business, improving its profitability, and delivering value to its shareholders. Investors may view these performances as a strong indication of ORA’s financial strength and future prospects, potentially leading to increased confidence in the company and its stock.

Tags: ORA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Supernus Pharmaceuticals Wins Patent Infringement Case Secures Exclusivity for Trokendi XR

Finance_Cash

Goldman Sachs Raises Price Target and Adds NVIDIA to Conviction List

Renewable energy

Theresa Chen Maintains EqualWeight Rating on Phillips 66 with Raised Price Target

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com